肝硬化并发肝性脑病的诱因和预后分析

doi:10.3969/j.issn.1672-5069.2015.05.028

Abstract

Chen Guangjian，Xie Bimei，Li Xiangxing，et al.. Factors influencing prognosis of patients with hepatic encephalopathy[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(5): 548-549.

[1] Khanna S，Gopalan S. Role of branched-chain amino acids in liver disease:the evidence for and against. Curr Opin Clin Nutr Metab Care，2010，10:297-303.
[2] 马雪梅，金波，孟繁平，等. 失代偿期丙型肝炎肝硬化患者长期随访研究. 传染病信息，2013，26（3）:161-163.
[3] Schulz GJ，Campos AC，Coelho JC. The role of nutrition in hepatic encephalopathy. Curr Opin Clin Nutr Metab Care，2011，11:275-280.
[4] 张文忠，杨跃杰，崔二平. 原发性胆汁性肝硬化患者免疫学指标特征分析. 实用肝脏病杂志，2014，7（5）：535-536
[5] Mesejo A，Juan M，Serrano A. Liver cirrhosis and encephalopathy:clinical and metabolic consequences and nutritional support. Nutr Hosp，2008，23（2）:8-18.
[6] 庄焱，谢青. 乙型肝炎肝硬化抗病毒治疗的新观点. 中华消化杂志，2012，32（8）:567-570.
[7] Cordoba J，Mínguez B. Hepatic encephalopathy. Semin Liver Dis，2010，28:70-80.
[8] 王芳，韩旭东. 终末期肝病模型、终末期肝病模型钠积分和CTP预测乙型肝炎肝硬化短期病死率价值研究. 临床荟萃，2008，23（18）:1339-1341.
[9] Li YY Nie YQ Sha WH，et al. Prevalence of subclinical hepatic encephalopathy in cirrhotic in China. Word J Gastroenterol，2012，10:2397-2401.
[10] 杨文龙，何金秋. 肝炎肝硬化并发肝性脊髓病一例报告. 实用临床医学，2009，10（1）:10-12.
[11] Vaquero J，Polson J，Chung C，et al. Infection and the progression of hepatic encephalopathy in acute liver failure. Gastroenterology，2009，125:755-764.
[12] 宗红梅，张银莉，马羽萍，等.解毒灌肠液治疗肝性脑病60例. 陕西中医，2014，（5）:527-528.
[13] Romeroweg M，Boza F，Garcia-Valdecasas MS，et al. Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol，2009，96（9）:2718.
[14] 刘素芬，胡瑞敏，苏国权，等. 乙型肝炎肝硬化患者医院内感染高危因素分析.临床荟萃，2007，22（13）:964-965.
[15] Cauli O，Rodrigo R，Piedrafita B，et al. Inflammation and hepatic encephalopathy:ibuprofen restores learning ability in rats with portacaval shunts. Hepatology，2011，46:514-519.

Factors influencing prognosis of patients with hepatic encephalopathy

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Zhuang Ying, Lin Zhihui.. Clinical manifestations and diagnosis of portal vein thrombosis [J]. Journal of Practical Hepatology, 2019, 22(6): 765-767.
[2]	Yang Caiyong, Chen Na, Li Kui, et al.. Clinical significance of peripheral blood Treg and Th17 cells in patients with chronic hepatitis C and hepatitis C-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 868-871.
[3]	Wu Dan Ma Xiangying.. Insulin resistance,carotid atherosclerosis and left ventricular function in patients with NAFLD-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 876-879.
[4]	He Zhi’an, Yu Liping, Lai Jiangqiong, et al.. Evaluation of varices bleeding and portal vein thrombosis by ARFI in patients with cirrhosis and esophagogastric varices [J]. Journal of Practical Hepatology, 2019, 22(6): 888-891.
[5]	Ma Yaqiong, Li Zhilan, Xia Bing.. Early administration of enteral nutrition and microecological agents in patients with hepatic encephalopathy [J]. Journal of Practical Hepatology, 2019, 22(6): 892-895.
[6]	Zhu Yucheng, Yan Jiawei, Sun Jingkun, et al. Serum diamine oxidase level in patients with hepatitis B-induced acute-on-chronic liver failure [J]. Journal of Practical Hepatology, 2019, 22(5): 672-675.
[7]	Wang Yueyuan, Wang Yan, Zhang Dandan. Short-term efficacy of terlipressin and octreotide combination in treatment of cirrhotic patients complicated by hepatorenal syndrome [J]. Journal of Practical Hepatology, 2019, 22(5): 684-687.
[8]	Zhang Mei, Shi Xiuying, Li Linjuan, et al. Hepatic expression of interferon inducible protein -10 in patients with hepatitis B liver cirrhosis and hepatogenic diabetes mellitus [J]. Journal of Practical Hepatology, 2019, 22(5): 688-691.
[9]	Dan Zhuyongji, Liu Zhilan, Lu Yanyan, et al. Efficacy of endoscopic sequential variceal 1igation plus sclerotherapy in treatment of patients with hepatitis B-induced liver cirrhosis complicated by esophageal gastric varices bleeding [J]. Journal of Practical Hepatology, 2019, 22(5): 692-695.
[10]	Huang Hanjun, Lu Fengrong, Zhang Can. Clinical value of MRI scanning based on exchange hemodynamics model in evaluating liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 696-699.
[11]	Zhao Fangfang, Zhai Yongzhen, Feng Guohe. Efficacy and safety of autologous peripheral blood stem cell transplantation in patients with hepatitis B cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 700-703.
[12]	Chen Shan, Zhuang Huashuai, Xing Yixi, et al. Preventive application of meropenem in patients with liver cirrhosis complicated by upper gastrointestinal bleeding [J]. Journal of Practical Hepatology, 2019, 22(5): 704-707.
[13]	Xu Qilin, Hao Shaohuan, Ran Bo. Risk factors of portal vein thrombosis after splenectomy in patients with liver cirrhosis and portal hypertension [J]. Journal of Practical Hepatology, 2019, 22(5): 708-711.
[14]	Jin Lianghong, Li Xingjie, Guan Hongbo, et al. Clinical value of dual-energy CT iodine quantification combined with dynamic contrast-enhanced MRI in evaluating hepatic hemodynamics and liver functions in patients with hepatitis B liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 712-715.
[15]	Bian Xinqu, Chen Jie, Liu Yanmin, et al. Serum thyroid hormone level changes in patients with primary biliary cholangitis receiving ursodeoxycholic acid therapy [J]. Journal of Practical Hepatology, 2019, 22(5): 716-719.